Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Nibrozetone by EpicentRx for Oral Mucositis: Likelihood of Approval
Nibrozetone is under clinical development by EpicentRx and currently in Phase II for Oral Mucositis. According to GlobalData, Phase II...
Data Insights
Nibrozetone by EpicentRx for Small-Cell Lung Cancer: Likelihood of Approval
Nibrozetone is under clinical development by EpicentRx and currently in Phase III for Small-Cell Lung Cancer. According to GlobalData, Phase...